# Handheld Surgical Devices Market

> Handheld Surgical Devices Market Research Report Information by Product Type (Graspers, Retractors, Mechanical Cutters, Suction Tips And Tubes, Irrigation And Injection Needs, Scopes And Probes, Sutures, Forceps, Tweezers, and Others), by Application (Orthopaedic Surgery, Ophthalmology, Cardiology, Wound Care, Urology And Gynecology Surgery, Plastic Surgery, Thoracic Surgery, Neurosurgery and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers and Others) and Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.42%
- **2024:** $ 6.62 Billion
- **2025:** $ 6.98 Billion
- **2035:** $ 11.83 Billion
- **Key Players:** Medtronic(US), Johnson & Johnson (US), Stryker (US), Boston Scientific (US), B. Braun Melsungen AG (DE), Smith & Nephew (GB), Zimmer Biomet (US), Conmed Corporation (US), Olympus Corporation (JP)

**Report ID:** MRFR/MED/5744-CR · **Pages:** 158 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/handheld-surgical-devices-market-7210

---

## Market Summary

## **Handheld Surgical Devices Market Overview**

Handheld surgical devices market share register 6.98 billion USD in 2025, projected to grow 5.42% CAGR during the forecast period (2025 - 2034). As per MRFR analysis, the handheld surgical devices market industry size is expected to grow from 6.62 billion USD in 2024 to 11.23 billion USD by 2034.

The growing prevalence of chronic disorders, such as cardiovascular, neurological, urological, and infectious diseases and increasing use of handheld devices in minimally invasive surgeries are major factors driving the growth of the Handheld Surgical Devices Market.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

In April 2024, NICO Corporation will introduce the Myriad SPECTRA System, a technology designed for the precise surgical removal of high-grade glioma brain tumors using fluorescence guidance. The novel portable technology is specifically engineered to aid surgeons in the fluorescence-guided excision of Grade III and IV gliomas. When used with suitable surgical microscopes, it has the ability to provide white light to enhance the visibility of tumors and clots, as well as blue light to assist in the surgical removal of gliomas using fluorescence guidance.

The Myriad SPECTRA System provides a distinct blend of lighting, removal, gathering, and conservation of biological tissue. This technique is suitable for surgeries that aim to treat brain tumors and intracerebral hemorrhages (ICH), which are regarded as the most severe and expensive types of strokes. The device is capable of accommodating both minimally invasive and open craniotomy surgical methods. NICO intends to introduce the device during the forthcoming American Association of Neurosurgical Surgeons (AANS) Annual Scientific Meeting in Chicago.

The device's versatile features enable surgeons to seamlessly transition between full-spectrum white light and additional blue excitation light, improving the surgical view while maintaining the precise positioning of surgical optics. It has recently obtained approval from the US Food and Drug Administration and is also officially authorized for sales and clinical usage by the UK’s Medicines and Healthcare products Regulatory Agency.

In August 2023, GE HealthCare introduced the Vscan Air SL, a handheld ultrasound device, at the European Society of Cardiology (ESC) Congress in Amsterdam, the Netherlands. This device combines proprietary image enhancing technology and the capability to perform both vascular and cardiac assessments at the point of care. GE HealthCare stated that the Vscan Air SL, a handheld ultrasound instrument, has improved sensitivity and resolution by utilizing the exclusive SignalMax and XDclear technology. According to GE HealthCare, the Vscan Air SL has a dual-headed probe that allows physicians to access sector and linear arrays on the same device.

This capacity makes it easier for clinicians to quickly analyze the vascular and heart health of patients. The increasing potency of portable ultrasound devices is revolutionizing patient treatment. Whether in a hospital ward or in a general practice setting, the ability to deliver imaging of excellent quality at the location where healthcare is provided is crucial for prompt diagnosis and treatment. 

## **Handheld Surgical Devices Trends**

Chronic diseases such as cardiovascular, neurological, urological, and infectious diseases are increasing globally. Heart disorders are becoming more common than other chronic diseases due to a lack of physical activity, being overweight, smoking, poor nutrition, or having a family history. Furthermore, diabetes, hypertension, and hyperlipidemia are all risk factors for cardiovascular disease. For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 20.1 million adults aged 20 and older had coronary artery disease in 2020. People over the age of 60 are at a higher risk of developing diseases such as cardiovascular, orthopedic, and neurological issues.

Some people with these conditions or diseases have to undergo surgery. Therefore, an increase in cardiovascular, orthopedic, and neurological issues is expected to boost the demand for handheld surgical devices. The use of high-quality devices by surgeons is a constant priority in order to execute surgeries efficiently and quickly without compromising the health of the patient. Therefore, variables that are causing a surge in the need for handheld surgical devices include the rising prevalence of chronic conditions like cardiovascular, neurological, urological, and infectious diseases.

## **Handheld Surgical Devices Segment Insights**

### **Handheld Surgical Devices Product Type Insights**

The Handheld Surgical Devices Market segmentation, based on product type, includes graspers, retractors, mechanical cutters, suction tips and tubes, irrigation and injection needs, scopes and probes, sutures, forceps, tweezers, and others. The forceps segment held the majority share in the market in 2022. Surgical forceps are grasping-type surgical devices used for clamping, tweezing, and applying pressure during surgeries and other procedures. They can have either tweezer-style handles or ring handles used to hold or grasp tissue, dressings, or other objects. There are two primary types of surgical forceps, including locking forceps and non-locking forceps.

Surgical forceps are important handheld surgical devices commonly made of high-grade carbon steel.

### **Handheld Surgical Devices Application Insights**

The Handheld Surgical Devices Market segmentation, based on application, includes orthopedic surgery, ophthalmology, cardiology, wound care, urology and gynecology surgery, plastic surgery, thoracic surgery, neurosurgery and others. The orthopedic surgery segment dominated the market in 2022. There is an increasing number of orthopedic surgeries around the globe. Knee and hip replacements are some of the most commonly performed and effective surgeries around the globe. For instance, according to the American College of Rheumatology, over 450,000 hip replacement surgeries and around 790,000 total knee replacement surgeries are performed per year in the US.

These increasing numbers of orthopedic surgeries are creating demand for orthopedic handheld surgical devices worldwide.

### **Handheld Surgical Devices End User Insights**

The Handheld Surgical Devices Market segmentation, based on end user, includes hospitals & clinics, ambulatory surgical centers and others. The hospital & clinics segment dominated the market in 2022. A majority of the people in developing regions such as China and India prefer hospitals & clinics as advanced treatment for various chronic diseases such as cardiovascular diseases, diabetes, cancer, and others. According to the Center for Disease Control and Prevention in 2019, the prevalence of chronic diseases in adults was around 60% globally, and it is reportedly much higher among elderly people.

It is estimated that about 70% of adults will die of one or more chronic diseases. Handheld surgical devices are used in various surgical applications for these chronic diseases. The rising prevalence of cardiovascular and other chronic disorders has further driven the growth of the segment.

**Figure 2: Handheld Surgical Devices Market, by End User, 2022 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Handheld Surgical Devices Regional Insights**

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. The North America handheld surgical devices market accounted for the largest market share in 2022. The North America regional market is the largest market in terms of revenue. The market is driven by the increasing prevalence of cardiovascular, cancer, neurological, and autoimmune disorders in this region. Some common surgeries in this region include circumcision, gallbladder removal, angioplasty, C-section, cataract removal, joint replacement, broken bone repair, and cardiovascular disorders.

For instance, according to a research article published in the Journal of the American Medical Association, the US had more than 13 million US surgical procedures from 2019 to 2021. Thus, such volume of surgeries promotes greater consumption of the market products.

Further, the major countries will be study are: The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 3: HANDHELD SURGICAL DEVICES MARKET BY REGION 2022 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

Europe handheld surgical devices market accounted for the second-largest market share due to the growing demand for safe surgical devices that are used in minimally invasive surgeries, rising research and development investments, and increasing geriatric population. Furthermore, the Germany handheld surgical devices market attributed to hold the largest market share, and the France handheld surgical devices market is projected be the fastest growing market in the Europe region.

The Asia-Pacific handheld surgical devices market is expected to be the fastest growing from 2023 to 2032 due to the growing population, the increasing spending power of consumers, and the high prevalence of chronic disorders. Moreover, China handheld surgical devices market accounted to hold the largest market share, and the India handheld surgical devices market is projected to be the fastest growing market in the Asia-Pacific region.

## **Handheld Surgical Devices Key Market Players & Competitive Insights**

Major market players’ growth is dependent on market conditions, government support, and industry development. The Handheld Surgical Devices Market is extremely competitive, with players competing, partnering, and investing heavily in research and development to gain a significant market share. The market is moderately fragmented with rising competition, product launches, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.

Integra Lifesciences Holdings Corporation (US) is a medical technology company. The key focus of the company is to provide patients with a high level of satisfaction. Integra LifeSciences provides and operates innovative solutions in the field of orthopedic extremity surgery, neurosurgery, and reconstructive & general surgery. Integra Life Sciences is one of the leading providers of surgical devices and instruments to various hospitals, surgery centers, physicians, and dental offices, in the US.

Moreover, In December 2022, Integra LifeSciences announced the acquisition of the Surgical Innovation Association (US). As per the agreement Integra paid USD 50 m at the closing of the deal, as well as up to USD 90 million more upon reaching some revenue as well as regulatory milestones.

### **Key Companies in the handheld surgical devices market includes.**

**Handheld Surgical Devices Industry Developments**

**September 2023:**Medline Industries Inc. (US) launched REFLEX TETRA Nitinol Staples at AOFAS 2023 Annual Meeting.  REFLEX TETRA four-leg staples are designed to fit the unique bone structures and anatomies of the MTP (metatarsophalangeal), first and lesser TMT (tarsometatarsal), and TN (talonavicular) joints

**April 2023:**Smith & Nephew (UK) introduces robotically enabled total knee arthroplasty CORI Digital Tensioner.  The purpose-built device that lets surgeons measure the ligament tension in a knee before cutting bone.

**January 2023:**Zimmer Biomet (US) has acquired Embody, Inc. (US), a privately held medical device company. The acquisition encompasses Embody's entire range of collagen-based biointegrative solutions, including TAPESTRY RC, one of the first arthroscopic implant systems for rotator cuff repair, and the biointegrative implant TAPESTRY for tendon healing, which support healing in the most challenging orthopedic soft tissue injuries.

## **Handheld Surgical Devices Segmentation**

### **Handheld Surgical Devices Product Type Outlook**

### **Handheld Surgical Devices Application Outlook**

### **Handheld Surgical Devices End User Outlook**

### **Handheld Surgical Devices Regional Outlook**

## Market Drivers

### Technological Advancements

The Global Handheld Surgical Devices Market Industry is experiencing a surge in technological advancements, which enhances surgical precision and efficiency. Innovations such as robotic-assisted handheld devices and advanced imaging technologies are transforming surgical procedures. For instance, the integration of augmented reality in surgical instruments allows surgeons to visualize complex anatomy in real-time, potentially reducing operation times and improving patient outcomes. As these technologies continue to evolve, they are expected to drive market growth significantly, contributing to the projected market value of 6.59 USD Billion in 2024. This trend indicates a shift towards more sophisticated surgical solutions.

## Future Outlook

The Handheld Surgical Devices Market is projected to grow at a 5.42% CAGR from 2025 to 2035, driven by technological advancements, increasing surgical procedures, and rising demand for minimally invasive surgeries.

**New opportunities:**

- Development of smart handheld devices with integrated AI for enhanced precision. Expansion into emerging markets with tailored product offerings. Partnerships with healthcare providers for training and support services.

By 2035, the market is expected to achieve substantial growth, reflecting evolving surgical needs and technological innovations.

## Segment Insights

### By Application: General Surgery (Largest) vs. Orthopedic Surgery (Fastest-Growing)

In the Handheld Surgical Devices Market, General Surgery currently holds the largest market share compared to other applications, driven by the breadth of procedures utilizing these devices, including laparoscopic surgeries and minimally invasive techniques. Orthopedic Surgery is rapidly gaining traction as the fastest-growing segment due to technological advancements in surgical tools that enhance precision and outcomes in joint and bone surgeries, creating increased demand for handheld devices tailored for orthopedic procedures.

General Surgery (Dominant) vs. Orthopedic Surgery (Emerging)

General Surgery remains the dominant application in the handheld surgical devices market, thanks to its extensive use across various surgical procedures that require precision and versatility. Tools designed for this segment often incorporate innovative features such as ergonomic designs and advanced materials to enhance surgical performance. In contrast, Orthopedic Surgery is emerging as a key segment, fueled by enhanced surgical techniques and a greater focus on patient outcomes. The reliance on handheld devices in orthopedic surgeries, particularly for joint replacements and fracture fixations, is skyrocketing, as practitioners increasingly require tools that facilitate minimally invasive methods, ultimately driving market growth in this segment.

### By Device Type: Scissors (Largest) vs. Electrosurgical Devices (Fastest-Growing)

In the Handheld Surgical Devices Market, scissors currently hold the largest market share due to their versatility and essential role in various surgical procedures. They are widely used across different surgical specialties, contributing significantly to their prominence among device types. Forceps and scalpels also capture notable shares, but scissors lead the segment driven by their common presence in [surgical kits](https://www.marketresearchfuture.com/reports/surgical-kit-market-43437) and procedure-specific adaptations. On the other hand, electrosurgical devices are identified as the fastest-growing segment within the handheld surgical devices market. This growth is attributed to technological advancements, increasing preference for minimally invasive surgeries, and the rise in surgical procedures. Consequently, electrosurgical devices are gaining traction as they offer improved precision and reduced recovery times for patients.

Scissors (Dominant) vs. Electrosurgical Devices (Emerging)

Scissors are the dominant force in the handheld surgical devices market, primarily due to their extensive application in a variety of surgical operations. Their designs cater to specific functions such as cutting sutures, tissue, and other materials, and they are manufactured in various shapes and sizes to suit different surgical needs. The established usage of scissors across surgical disciplines, along with their reliability and effectiveness, positions them as an essential tool in any surgical setting. In contrast, electrosurgical devices represent an emerging trend within the market, driven by advancements in technology that enhance surgical efficiency. They enable precise cutting and coagulation during surgeries, thereby minimizing blood loss and enhancing recovery times. As hospitals increasingly favor these devices for their benefits, their market position is strengthening, indicating favorable growth prospects.

### By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Handheld Surgical Devices Market, hospitals hold the largest share due to their extensive use of advanced surgical tools for complex procedures. This sector relies heavily on handheld devices such as scalpels, forceps, and electrosurgical instruments, which are essential for various surgical operations. Ambulatory Surgical Centers are also significant players in the market, catering to outpatient surgeries. Their share is growing, reflecting a shift towards less invasive procedures and shorter recovery times.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals represent the dominant sector in the Handheld Surgical Devices Market due to their capability to conduct a wide range of surgical procedures requiring precise instruments. These facilities invest heavily in the latest handheld surgical technologies to enhance patient outcomes and operational efficiency. In contrast, Ambulatory Surgical Centers are emerging rapidly, leveraging cost-effectiveness and convenience to attract patients seeking outpatient procedures. This segment is capitalizing on the trend towards minimally invasive surgeries, providing high-quality care in a lower-cost setting, thus driving significant growth in the handheld devices demand.

### By Technology: Robotic-Assisted (Largest) vs. Ultrasonic (Fastest-Growing)

In the Handheld Surgical Devices Market, the technology segment exhibits a diverse distribution of market shares across various devices. Robotic-Assisted devices lead this segment, capturing the largest share, followed by Electromechanical and Laser devices. Manual devices, while historically standard, have seen a decline in preference due to advancements in technology. Ultrasonic devices are gaining traction, indicating a shift towards more sophisticated surgical options that aid in precision and efficiency. Growth trends in the technology segment are primarily driven by developments in minimally invasive surgical techniques and rising preference for advanced robotic systems. Increasing demand for precision surgery and improved patient outcomes are significant motivators for the adoption of robotic-assisted devices, while the ultrasonics category demonstrates the fastest growth, leveraging benefits such as reduced tissue damage and postoperative recovery time. This trend reflects a broader movement towards innovative, less invasive surgical practices in healthcare.

Technology: Robotic-Assisted (Dominant) vs. Ultrasonic (Emerging)

Robotic-Assisted devices are at the forefront of the Handheld Surgical Devices Market, providing surgeons with enhanced precision and control during procedures. These technologies are particularly favored in complex surgeries due to their ability to reduce human error and improve patient outcomes. Their dominance stems from significant investments in research and development, leading to advanced systems that seamlessly integrate into surgical workflows. On the other hand, Ultrasonic devices are emerging as a pivotal segment, characterized by their capability to perform delicate tissue dissections with minimal thermal damage. As healthcare providers increasingly prioritize minimally invasive options, ultrasonic devices are rapidly expanding their market presence, appealing to surgeons seeking innovative tools that facilitate faster healing and better patient care.

### By Material: Stainless Steel (Largest) vs. Titanium (Fastest-Growing)

The Handheld Surgical Devices Market exhibits a diverse material composition, with stainless steel dominating due to its strength, durability, and ease of sterilization. Following closely are titanium and composite materials, valued for their superior characteristics such as lightweight and resistance to corrosion. Plastic and ceramic segments hold smaller shares, primarily serving specialized applications where affordability and advanced properties are paramount. Growth trends in the material segment are shaped by advancements in technology and increasing demand for lightweight surgical instruments. Titanium is rapidly emerging due to its favorable properties and biocompatibility, leading to its increasing use in complex procedures. Additionally, the rise in outpatient surgeries and a growing emphasis on minimally invasive techniques drive innovation and demand for varied materials in handheld surgical devices.

Stainless Steel (Dominant) vs. Titanium (Emerging)

Stainless steel remains the dominant material in the handheld surgical devices market due to its robust mechanical properties and resistance to corrosion, making it ideal for reuse in surgical settings. Its affordability and proven performance solidify its position among surgeons. In contrast, titanium is being recognized as an emerging material, particularly favored for its lightweight nature and superior strength-to-weight ratio. Its uses are expanding due to biocompatibility, making it suitable for implants and complex surgeries. The growth in this segment reflects a shift towards advanced materials, as it offers promising potential for enhanced surgical outcomes and patient safety.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America continues to lead the handheld surgical devices market, holding a significant share of 3.5 billion in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing surgical procedures, and a rising demand for minimally invasive surgeries. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, ensuring high standards in surgical practices. The competitive landscape is robust, with key players such as Medtronic, Johnson & Johnson, and Stryker dominating the market. The presence of these industry giants fosters a culture of innovation and quality, contributing to the region's market strength. Additionally, the U.S. healthcare system's focus on improving patient outcomes drives the demand for advanced handheld surgical devices, solidifying North America's position as a market leader.

### Europe : Emerging Market with Growth Potential

Europe's handheld surgical devices market is valued at 1.8 billion, reflecting a growing demand for innovative surgical solutions. Factors such as an aging population, increasing prevalence of chronic diseases, and advancements in surgical technologies are propelling market growth. Regulatory frameworks, including the EU Medical Device Regulation, ensure safety and efficacy, fostering consumer confidence in new products. Leading countries like Germany, France, and the UK are at the forefront of this market, supported by strong healthcare systems and significant investments in medical technology. Key players such as B. Braun Melsungen AG and Smith & Nephew are enhancing their product offerings to meet the evolving needs of healthcare providers. The competitive landscape is characterized by collaborations and partnerships aimed at driving innovation and expanding market reach.

### Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific region is witnessing a surge in the handheld surgical devices market, currently valued at 1.2 billion. This growth is fueled by increasing healthcare expenditure, rising surgical procedures, and a growing awareness of advanced surgical techniques. Governments are investing in healthcare infrastructure, which is expected to further enhance market dynamics and accessibility to innovative surgical solutions. Countries like Japan, China, and India are leading the charge, with a mix of local and international players competing for market share. Companies such as Olympus Corporation are expanding their presence in the region, focusing on product innovation and strategic partnerships. The competitive landscape is evolving, with a strong emphasis on affordability and accessibility to meet the diverse needs of the population, driving the market forward.

### Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa region represents a nascent market for handheld surgical devices, valued at 0.12 billion. Despite challenges such as regulatory hurdles and varying healthcare standards, the region is gradually witnessing growth driven by increasing investments in healthcare infrastructure and rising surgical needs. Governments are focusing on improving healthcare access, which is expected to boost demand for advanced surgical devices in the coming years. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities adopting innovative surgical technologies. However, the competitive landscape remains fragmented, with both local and international players vying for market presence. Companies are focusing on tailored solutions to meet regional needs, which is crucial for capturing market share in this developing landscape.

## Competitive Benchmarking

The Handheld Surgical Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing surgical procedures, and a growing emphasis on minimally invasive techniques. Key players such as Medtronic (US), Johnson & Johnson (US), and Stryker (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on innovation through the development of advanced surgical instruments, while Johnson & Johnson (US) emphasizes strategic partnerships to expand its product offerings. Stryker (US) is actively pursuing mergers and acquisitions to bolster its portfolio, indicating a trend towards consolidation in the market. Collectively, these strategies contribute to a competitive environment that is increasingly shaped by technological innovation and strategic collaborations.In terms of business tactics, companies are localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where several players vie for market share. The competitive structure is influenced by the collective actions of these key players, who are leveraging their strengths to optimize operations and respond to evolving market demands. The focus on supply chain optimization is critical, especially as companies seek to mitigate risks associated with global disruptions.
In November Medtronic (US) announced the launch of a new handheld surgical device designed for orthopedic procedures, which integrates AI technology to assist surgeons in real-time decision-making. This strategic move not only enhances Medtronic's product line but also positions the company as a leader in the integration of AI within surgical devices, potentially improving patient outcomes and operational efficiency. The introduction of such innovative solutions reflects a broader trend towards the incorporation of advanced technologies in surgical practices.
In October Johnson & Johnson (US) entered into a partnership with a leading robotics firm to develop next-generation handheld surgical instruments. This collaboration aims to combine robotics with traditional surgical techniques, thereby enhancing precision and reducing recovery times for patients. The strategic importance of this partnership lies in its potential to redefine surgical standards and expand Johnson & Johnson's market reach, aligning with the growing demand for minimally invasive procedures.
In September Stryker (US) completed the acquisition of a smaller competitor specializing in handheld surgical tools, thereby expanding its product portfolio and market share. This acquisition is indicative of Stryker's aggressive growth strategy and highlights the trend of consolidation within the industry. By integrating new technologies and expertise, Stryker aims to enhance its competitive edge and respond more effectively to customer needs.
As of December the Handheld Surgical Devices Market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. These trends are reshaping the competitive landscape, with strategic alliances becoming increasingly vital for innovation and market differentiation. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that companies must prioritize innovation to maintain a competitive advantage in this evolving market.

## Recent News & Developments

**September 2023:**Medline Industries Inc. (US) launched REFLEX TETRA Nitinol Staples at AOFAS 2023 Annual Meeting.  REFLEX TETRA four-leg staples are designed to fit the unique bone structures and anatomies of the MTP (metatarsophalangeal), first and lesser TMT (tarsometatarsal), and TN (talonavicular) joints

**April 2023:**Smith & Nephew (UK) introduces robotically enabled total knee arthroplasty CORI Digital Tensioner.  The purpose-built device that lets surgeons measure the ligament tension in a knee before cutting bone.

**January 2023:**Zimmer Biomet (US) has acquired Embody, Inc. (US), a privately held [medical device](https://www.marketresearchfuture.com/reports/medical-devices-market-2869)company. The acquisition encompasses Embody's entire range of collagen-based biointegrative solutions, including TAPESTRY RC, one of the first arthroscopic implant systems for rotator cuff repair, and the biointegrative implant TAPESTRY for tendon healing, which support healing in the most challenging orthopedic soft tissue injuries.

## Report Scope

| MARKET SIZE 2024 | 6.62(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.98(USD Billion) |
| MARKET SIZE 2035 | 11.83(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.42% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Johnson & Johnson (US), Stryker (US), Boston Scientific (US), B. Braun Melsungen AG (DE), Smith & Nephew (GB), Zimmer Biomet (US), Conmed Corporation (US), Olympus Corporation (JP) |
| Segments Covered | Application, Device Type, End User |
| Key Market Opportunities | Integration of advanced robotics and artificial intelligence in Handheld Surgical Devices Market enhances precision and efficiency. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the handheld surgical devices market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Handheld Surgical Devices Market by 2035?**
A: The Handheld Surgical Devices Market is projected to reach a valuation of 11.83 USD Billion by 2035.

**Q: What was the market valuation of the Handheld Surgical Devices Market in 2024?**
A: In 2024, the Handheld Surgical Devices Market was valued at 6.62 USD Billion.

**Q: What is the expected CAGR for the Handheld Surgical Devices Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Handheld Surgical Devices Market during the forecast period 2025 - 2035 is 5.42%.

**Q: Which application segment is anticipated to have the highest growth in the Handheld Surgical Devices Market?**
A: The General Surgery segment is anticipated to grow from 1.98 USD Billion in 2024 to 3.5 USD Billion by 2035.

**Q: What are the leading companies in the Handheld Surgical Devices Market?**
A: Key players in the Handheld Surgical Devices Market include Medtronic, Johnson & Johnson, Stryker, and Boston Scientific.

**Q: How does the market for electrosurgical devices compare to other device types?**
A: Electrosurgical devices are expected to grow from 2.0 USD Billion in 2024 to 3.8 USD Billion by 2035, indicating strong demand.

**Q: What is the projected growth for the hospitals segment in the Handheld Surgical Devices Market?**
A: The hospitals segment is projected to increase from 2.65 USD Billion in 2024 to 4.65 USD Billion by 2035.

**Q: Which material segment is expected to see the most significant growth?**
A: The Stainless Steel material segment is expected to grow from 2.0 USD Billion in 2024 to 3.5 USD Billion by 2035.

**Q: What is the anticipated growth for robotic-assisted handheld surgical devices?**
A: Robotic-assisted handheld surgical devices are expected to grow from 1.0 USD Billion in 2024 to 2.0 USD Billion by 2035.

**Q: How does the market for specialty clinics compare to ambulatory surgical centers?**
A: The specialty clinics segment is projected to grow from 1.15 USD Billion in 2024 to 2.05 USD Billion by 2035, while ambulatory surgical centers are expected to grow from 1.25 USD Billion to 2.25 USD Billion.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/handheld-surgical-devices-market-7210*